logo-loader
viewMan Group

Man Group says outlook "mixed" as funds fall in third quarter

Looking ahead, chief executive Luke Ellis said the board was “encouraged by our good performance fee earning potential, although uncertain economic conditions mean the outlook for flows remains mixed”

Man Group - CEO Luke Ellis
Man CEO Luke Ellis

Man Group Plc (LON:EMG) was hit by $1.1bn of net outflows in its third quarter and $1.3bn of currency swings and other negative impacts, which was only partly offset by positive investment movement.

All in all, the hedge fund manager’s funds under management (FuM) fell $1.7bn, or 1.5%, to $112.7bn over the three months to 30 September.

Over the year to date, FuM is up 4%.

“In the third quarter, we saw a continuation of the trends experienced in the first half of the year with strong absolute performance and inflows into our quant alternative strategies, and outflows from our long only equity strategies,” said chief executive Luke Ellis.

Looking ahead, Ellis said the board was “encouraged by our good performance fee earning potential, although uncertain economic conditions mean the outlook for flows remains mixed”.

With cash flowing, Man announce its intention to buy back $100mln of shares and said the company “will continue to review further potential acquisition opportunities”.

Quick facts: Man Group

Price: 153.7 GBX

LSE:EMG
Market: LSE
Market Cap: £2.33 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 17 hours ago

RNS

Transaction in Own Shares

1 day, 10 hours ago

Transaction in Own Shares

2 days, 20 hours ago

Transaction in Own Shares

4 days, 10 hours ago

Transaction in Own Shares

5 days, 10 hours ago

Transaction in Own Shares

5 days, 21 hours ago

2 min read